Structure-based calculation of drug efficiency indices

Bioinformatics

Volumn 23, Issue 20, 2007, Pages 2678-2685

  Hetényi, Csaba ^a,b   Maran, Uko ^a   García Sosa, Alfonso T ^a   Karelson, Mati ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; AMILORIDE; AMINOCAPROIC ACID; AMODIAQUINE; AMPRENAVIR; ARGATROBAN; BETA SECRETASE; CAPTOPRIL; DEXAMETHASONE; ETACRYNIC ACID; GEMCITABINE; HYDROCORTISONE; IMMUNOGLOBULIN; METHOTREXATE; NELFINAVIR; NICOTINE; NORETHISTERONE; NOVOBIOCIN; PROTEINASE; PYRIMETHAMINE; RALTITREXED; RITONAVIR; STREPTAVIDIN; TACROLIMUS;

ALZHEIMER DISEASE; ARTICLE; BINDING AFFINITY; BIOCHEMISTRY; CALCULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG PROTEIN BINDING; DRUG RESEARCH; HIGH THROUGHPUT SCREENING; MACROMOLECULE; MATHEMATICAL COMPUTING; METHODOLOGY; PHARMACODYNAMICS; PRIORITY JOURNAL; THERMODYNAMICS; VALIDATION PROCESS;

EID: 35748962598     PISSN: 13674803     EISSN: 13674811     Source Type: Journal    
DOI: 10.1093/bioinformatics/btm431     Document Type: Article

References (42)

1. Abad-Zapatero,C. and Metz,J.T. (2005) Ligand efficiency indices as guideposts for drug discovery. Drug Discov. Today, 10, 464-469.
2. Balaban,A.T. (1982) Highly discriminating distance based topological index. Chem. Phys. Lett., 89, 399-404.
3. Berman,H.M. et al. (2000) The Protein Data Bank. Nucleic Acids Res., 28, 235-242.
4. Brooijmans,N. and Kuntz,I.D. (2003) Molecular recognition and docking algorithms. Annu. Rev. Biophys. Biomol. Struct., 32, 335-373.
5. Calderone,C.T. and Williams,D.H. (2001) An enthalpic component in cooperativity: The relationship between enthalpy, entropy, and noncovalent structure in weak associations. J. Am. Chem. Soc., 123, 6262-6267.
6. Campoy,A.V. and Freire,E. (2005) ITC in the post-genomic era...? Priceless. Biophys. Chem., 115, 115-124.
7. Carlsson,J. and Åqvist,J. (2005) Absolute and relative entropies from computer simulation with applications to ligand binding. J. Phys. Chem. B, 109, 6448-6456.
8. Chen,W. et al. (2006) Concepts in receptor optimization: Targeting the RGD peptide. J. Am. Chem. Soc., 128, 4675-4684.
9. DeLano,W.L. (2006) PyMol Molecular Graphics System. DeLano Scientific, San Carlos, CA, USA:
10. Devillers,J. and Balaban,A.T. (eds.) (1999) Topological Indices and Related Descriptors in QSAR and QSPR. Gordon and Beach Science Publishers, Amsterdam.
11. Hetényi,C. et al. (2006) Combination of a modified scoring function with two-dimensional descriptors for calculation of binding affinities of bulky, flexible ligands to proteins. J. Am. Chem. Soc. 128, 1233-1239.
12. Hong,L. et al. (2000) Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor. Science, 290, 150-153.
13. Hopkins,A.L. et al. (2004) Ligand efficiency: A useful metric for lead selection. Drug Discov. Today, 9, 430-431.
14. Huey,R. et al. (2007) A semiempirical free energy force field with charge-based desolvation. J. Comput. Chem., 28, 1145-1152.
15. Karelson,M. (2000) Molecular Descriptors in QSAR/QSPR. J. Wiley & Sons, New York.
16. Karelson,M. et al. (1996) Quantum-chemical descriptors in QSAR/ QSPR studies. Chem. Rev., 96, 1027-1043.
17. Katritzky,A.R. et al. (1995) QSPR:tHe correlation and quantitative prediction of chemical and physical properties from structure. Chem. Soc. Rev., 24, 279-287.
18. Katritzky,A.R. et al. (1996) Correlation of boiling points with molecular structure. 1. A training set of 298 diverse organics and a test set of 9 simple inorganics. J. Phys. Chem., 100, 10400-10407.
19. Keseru,G.M. and Makara,G.M. (2006) Hit discovery and hit-to-lead approaches. Drug Discov. Today, 11, 741-748.
20. Kier,L.B. (1990) Rouvray,D.H. (ed.) Computational Chemical Graph Theory. Nova Science Publishers, New York, pp. 151-174.
21. Kier,L.B. and Hall,L.H. (1976) Molecular Connectivity in Chemistry and Drug Reasearch. Academic Press, New York.
22. Kuntz,I.D. et al. (1999) The maximal affinity of ligands. Proc. Natl Acad. Sci. USA, 96, 9997-10002.
23. Lindstrom,W.H. et al. (2003) The NCI Diversity Set for AutoDock. http://autodock.scripps.edu/resources/databases
24. Lipinski,C. and Hopkins,A. (2004) Navigating chemical space for biology and medicine. Nature, 432, 855-861.
25. Lipinski,C.A. et al. (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev., 23, 3-25.
26. Morris,G.M. et al. (1996) Distributed automated docking of flexible ligands to proteins: Parallel applications of AutoDock 2.4. J. Comput. Aided Mol. Des., 10, 293-304.
27. Morris,G.M. et al. (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem., 19, 1639-1662.
28. Murphy,K.P. (1999) Predicting binding energetics from structure: Looking beyond DeltaG degrees. Med. Res. Rev., 19, 333-339.
29. Murray,C.W. and Verdonk,M.L. (2002) The consequences of translational and rotational entropy lost by small molecules on binding to proteins. J. Comput. Aided Mol. Des., 16, 741-753.
30. NCI/NIH, National Cancer Institute, Developmental Therapeutics Program. http://dtp.nci.nih.gov/branches/dscb/diversity_explanation.html.
31. Noskov,S.Y. and Lim,C. (2001) Free energy decomposition of protein-protein interactions. Biophys. J., 81, 737-750.
32. Randić,M. (1975) On characterization of molecular branching. J. Am. Chem. Soc., 97, 6609-6615.
33. Ren,P. and Ponder,J.W. (2003) Polarizable atomic multipole water model for molecular mechanics simulation. J. Phys. Chem. B, 107, 5933-5947.
34. Rishton,G.M. (2003) Nonleadlikeness and leadlikeness in biochemical screening. Drug Discov. Today, 8, 86-96.
35. Schuffenhauer,A. et al. (2006) Relationships between molecular complexity, biological activity, and structural diversity. J. Chem. Inf. Model., 46, 525-535.
36. Stouten,P.F.W. et al. (1993) An effective solvation term based on atomic occupancies for use in protein simulations. Mol. Simul., 10, 97-120.
37. Swinney,D.C. (2004) Biochemical mechanisms of drug action: What does it take for success? Nat. Rev. Drug Discov., 3, 801-808.
38. Swinney,D.C. (2006) Biochemical mechanisms of new molecular entities (NMEs) approved by United States FDA during 2001-2004: Mechanisms leading to optimal efficacy and safety. Curr. Top. Med. Chem., 6, 461-478.
39. Wang,R. et al. (2004) The PDBbind database: Collection of binding affinities for protein-ligand complexes with known three-dimensional structures. J. Med. Chem., 47, 2977-2980.
40. Wiener,H. (1947) Structural determination of paraffin boiling points. J. Am. Chem. Soc., 69, 17-20.
41. Yang,J.-M. and Tung,C.-H. (2006) Protein structure database search and evolutionary classification. Nucleic Acids Res., 34, 3646-3659.
42. Zou,X. et al. (1999) Inclusion of solvation in ligand binding free energy calculations using the generalized-Born model. J. Am. Chem. Soc., 121, 8033-8043.